Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Pediatric Rheumatology
Published in: Pediatric Rheumatology 1/2024

Open Access 01-12-2024 | Kawasaki Disease | Research article

Kawasaki disease in Kenya and review of the African literature

Authors: A. Migowa, CM. Njeru, E. Were, T. Ngwiri, I. Colmegna, C. Hitchon, R. Scuccimarri

Published in: Pediatric Rheumatology | Issue 1/2024

Login to get access

Abstract

Background

Kawasaki disease has been described across the globe, although publications from Africa are limited. To our knowledge, there are no publications on Kawasaki disease from Kenya, which triggered this report.

Methods

A retrospective cross-sectional study was undertaken to identify in-patients with a discharge diagnosis of Kawasaki disease, over 2 different 5-year periods, at two pediatric hospitals in Nairobi, Kenya. We reviewed the medical records of all patients and report their clinical findings, diagnostic workup and treatment. In addition, we undertook a detailed review of the literature.

Results

Twenty-three patients with Kawasaki disease were identified, of those 12 (52.2%) had incomplete disease. The mean age was 2.3 years (SD+/-2.2) (range 0.3–10.3) with a male to female ratio of 1:1. The mean duration of fever at diagnosis was 8.3 days (SD+/-4.7) (range 2–20). Oral changes were the most common clinical feature and conjunctivitis the least common. Thrombocytosis at diagnosis was seen in 52% (12/23). Twenty-one patients (91.3%) were treated with intravenous immunoglobulin and all except 1 received aspirin. Baseline echocardiograms were performed in 95.7% (22/23) and found to be abnormal in 3 (13.6%). Follow-up data was limited. Our literature review identified 79 publications with documented cases of Kawasaki disease in children from 22 countries across the African continent with a total of 1115 patients including those from this report. Only 153 reported cases, or 13.7%, are from sub-Saharan Africa.

Conclusions

This is the first publication on Kawasaki disease from Kenya and one of the largest reports from sub-Saharan Africa. It is the first to have a complete review of the number of published cases from the African continent. Challenges in the diagnosis and management of Kawasaki disease in many African countries include disease awareness, infectious confounders, access and cost of intravenous immunoglobulin, access to pediatric echocardiography and follow-up. Increasing awareness and health care resources are important for improving outcomes of Kawasaki disease in Africa.
Appendix
Available only for authorised users
Literature
1.
McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki Disease: A scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927–99.PubMedCrossRef
2.
Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi (Japanese). 1967;16:178–222.
3.
4.
5.
Singh S, Newburger JW, Kuijpers T, Burgner D. Management of Kawasaki Disease in resource-limited settings. Pediatr Infect Dis J. 2015;34(1):94–6.PubMedCrossRef
6.
Animasahun AB, Adekunle MO, Kusimo OY. Reactivation of BCG scar as a useful tool in the diagnosis of Kawasaki’s disease: a case report. Curr Res Cardiol. 2017;4(1):7–8.CrossRef
7.
Singh S, Kawasaki T. Kawasaki Disease in India, lessons learnt over the last 20 years. Indian Pediatr. 2016;53(2):119–24.PubMedCrossRef
8.
Singh S, Sharma A, Jiao F. Kawasaki Disease: issues in diagnosis and treatment– a developing country perspective. Indian J Pediatr. 2016;83(2):140–5.PubMedCrossRef
9.
Gewitz MH, Baltimore RS, Tani LY, Sable CA, Shulman ST, Carapetis J, et al; American Heart Association Committee on RheumaticFever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young. Revision of the Jones criteria for the diagnosis of acute rheumatic fever in the era of doppler echocardiography: a scientific statement from the American Heart Association. Circulation. 2015;131(20):1806–18.PubMedCrossRef
10.
11.
12.
Migowa A, Colmegna I, Hitchon C, Were E, Ng’ang’a E, Ngwiri T, et al. The spectrum of rheumatic in-patient diagnoses at a pediatric hospital in Kenya. Pediatr Rheumatol Online J. 2017;15(1):4.PubMedPubMedCentralCrossRef
13.
Van der Merwe PL, Gie RP, Hunter J, Mouton SCE, Schwar GT, Gleeson CM. Mucocutaneous lymph node syndrome (Kawasaki disease). A report of 2 cases. S Afr Med J. 1980;58(25):1014–6.PubMed
14.
Kibel MA, Jaffe IP, Ryder C. Kawasaki disease. S Afr Med J. 1980;58(1):6.PubMed
15.
Condat JM, Chauvet J, Mourieras P. Kawasaki syndrome in an infant from the Ivory Coast. First African case. Nouv Presse Med. 1981;10(4):251.PubMed
16.
Hedoui MM, Samoud A, Zaïmi I, Ben Dridi MF, Saddem TA, Ben Othman T, et al. Kawasaki syndrome in Tunisia. Apropos of 2 new cases. Tunis Med. 1987;65(5):343–7.PubMed
17.
Barabe P, Mbaye E, Peghini M, Brullard B, Gueye PM. First Senegalese case of Kawasaki’s disease. Presse Med. 1987;16(39):1977–8.PubMed
18.
Rothberg AD. Kawasaki syndrome in the Johannesburg area. S Afr Med J. 1988;73(4):254–5.PubMed
19.
20.
Gilbert RD, De Moor MMA. Myocardial infarction in Kawasaki disease. S Afr Med J. 1989;75:494–6.PubMed
21.
Ikpatt NW, Ibia EO. Mucocutaneous lymph node syndrome in Calabar-a case report. East Afr Med J. 1989;66(11):776–81.PubMed
22.
Gear JHS, Meyers KEC, Steele M. Kawasaki disease manifesting with acute cholangitis a case report. S Afr Med J. 1992;81:31–3.PubMed
23.
Esser M, Cotton M, Bouic P. Immunological status of children with Kawasaki syndrome. S Afr Med J. 1992;81(4):229–30.PubMed
24.
Elamin A. Kawasaki disease in a Sudanese family. Ann Trop Pediatr. 1993;13(3):263–8.CrossRef
25.
Waggie Z, Van Der Merwe PL, Kalis NN. Kawasaki disease masquerading as anomalous origin of left coronary artery from the pulmonary artery. S Afr Med J. 1999;89:suppl3. CI57·CI60.
26.
Mouko A, Nkoua JL, Louaka-Samba C, Mamadou B, Senga P. Kawasaki syndrome: apropos of 2 cases observed in Brazzaville. Bull Soc Pathol Exot. 2001;94(2):109–11.PubMed
27.
Tabarki B, Mahdhaoui A, Selmi H, Yacoub M, Essoussi AS. Kawasaki disease with predominant central nervous system involvement. Pediatr Neurol. 2001;25(3):239–41.PubMedCrossRef
28.
Mahdhaoui A, Tabarki B, Yaacoub M, Amri F, Essoussi S, Ammar H. Manifestations cardiovasculaires du syndrome de Kawasaki: Apport de l’échocardiographie dans le diagnostic et l’évolution. Tunis Med. 2003;81(11):879–84.PubMed
29.
Chemli J, Kchaou H, Amri F, Belkadhi A, Essoussi AS, Gueddiche N, et al. Clinical features and course of Kawasaki disease in central Tunisia: a study about 14 cases collected over a period of three years (2000–2002). Tunis Med. 2005;83(8):477–83.PubMed
30.
Rakotovao DN, Miandrisoa RM, Ramanitrarivo VL, Rakotonirina G, Rakotomamonjy SP, Imbert P. Kawasaki Disease: a case report from Madagascar. Med Trop. 2008;68(6):637–9.
31.
Hendricks M, Pillay S, Davidson A, De Decker R, Lawrenson J. Kawasaki disease preceding haemophagocytic lymphohistiocytosis: challenges for developing world practitioners. Pediatr Blood Cancer. 2010;54(7):1023–5.PubMedCrossRef
32.
Bouaziz Abed A, Mustapha R, Chiha M, Gannouni S, Farid O, Bousnina S. Les atteintes cardio-vasculaires dans la maladie de Kawasaki. Resultats d’une étude Tunisienne multicentrique. Rev Maghr Pédiatr. 2010;20(4):181–9.
33.
Kourda M, Bouaziz A, Tougourti MN. Lésions nécrotiques de la face au cours de la maladie de Kawasaki [Necrotic lesions of the face in Kawasaki disease]. Arch Pediatr. 2010;17(12):1667–9.PubMedCrossRef
34.
Sotimehin SA, Ogunlesi TA, Adekanmbi AF, Fetuga MB, Odumuyiwa EA, Olowu OA. Kawasaki Disease in a Nigerian child- a case report. Niger Med Pract. 2010;57(4).
35.
Rabesandratana N, Ralison F, Rakotoarison RA, Andrianarimanana D, Ralison G. Maladie de Kawasaki et manifestations buccales chez un enfant malgache. Revue d’odontostomatologie malgache en ligne. 2011;2:1–8.
36.
Badoe EV, Neequaye J, Oliver-Commey JO, Amoah J, Osafo A, Aryee I, et al. Kawasaki disease in Ghana: case reports from Korle Bu teaching hospital. Ghana Med J. 2011;45(1):38–42.PubMedPubMedCentralCrossRef
37.
Chemli J, Hassayoun S, Ketata S, Houda A, Mokni M, Zouari N, Abroug S, Harbi A. Kawasaki disease, Mycoplasma pneumoniae infection and anaplastic large cell lymphoma: an uncommon association. Open J Pediatr. 2012;2(03):250.CrossRef
38.
Kaouthar H, Rafik B, Jihen A, Imen H, Lilia C, Fatma O, Hela M. Giant aortic arch aneurysm complicating Kawasaki disease: an original case report. Cardiol Tunis. 2013;9(1):28–31.PubMedPubMedCentral
39.
40.
Sani UM, Ahmed H. Kawasaki disease: an unusual presentation in a 14-year old boy in Sokoto, north western Nigeria. Niger J Paed. 2013;40:422–5.
41.
Wilson SE, Chinyere UC, Queennette D. Childhood acquired heart disease in Nigeria: an echocardiographic study from three centres. Afr Health Sci. 2014;14(3):609–16.PubMedPubMedCentralCrossRef
42.
43.
Mabiala Babela JR, Ollandzobo Ikobo LC, Nika RE, Moyen G. Study of 11 new cases of Kawasaki disease Congolese. Bull Soc Pathol Exot. 2015;108(4):250–4.PubMedCrossRef
44.
Sani UM, Ahmed H, Jiya NM. Pattern of acquired heart diseases among children seen in Sokoto, NorthWestern Nigeria. Niger J Clin Pract. 2015;18(6):718–25.PubMedCrossRef
45.
Utuk EE, Akpan ME. Kawasaki disease in a two year old Nigerian child; full recovery with supportive treatment. IBOM Med J. 2015;8(1):18–22.CrossRef
46.
Raiman S, Knight DE, Eley B, Welzel TB. Use of polyclonal intravenous immunoglobulin at a paediatric referral hospital in South Africa between 2009 and 2012. J Clin Immunol. 2015;35:668–74.PubMedCrossRef
47.
Boudiaf H, Achir M. The clinical profile of Kawasaki Disease in Algerian children: a single institution experience. J Trop Pediatr. 2016;62(2):139–43.PubMedCrossRef
48.
Boudiaf H, Gherbi M, Achir M. Super giant coronary aneurysm in an Algerian boy with Kawasaki Disease. Int J Pediatr Res. 2016;2:021.CrossRef
49.
Gorrab AA, Fournier A, Bouaziz AA, Spigelblatt L, Scuccimarri R, Mrabet A et al. Incidence rate and epidemiological and clinical aspects of Kawasaki Disease in children of Maghrebi origin in the province of Quebec, Canada, compared to the country of origin. Glob Pediatr Health 2016 Feb 16;3:2333794X16630670.
50.
Kombaté K, Teclessou JN, Douti NK, Saka B, Akakpo AS, Mouhari-Touré A, et al. Kawasaki disease: first observation in a Togolese child 3 years old. Our Dermatol Online. 2016;7(4):459–64.CrossRef
51.
Tochie JN, Tchokam LT, Aminde LN, Monebenimp F. Kawasaki disease in an infant: diagnostic and therapeutic challenges at the University Teaching Hospital of Yaoundé. Cameroon JMR. 2016;2(5):135–8.
52.
Animasahun BA, Akinola A, Adekunle MO, Gbelee HO. Kawasaki Disease: does it affect children in Lagos. Nigeria? J Cardiol Cardiovasc Ther. 2016:1(3).
53.
Animasahun A, Adekunle M, Kusimo O, Fadipe C. The diagnosis of Kawasaki disease among Nigerian children: a nightmare for the caregivers and the doctors. J Public Health Emerg. 2017;1(7).
54.
Animasahun BA, Madise-Wobo AD, Kusimo OY. Nigerian children with acquired heart disease: the experience in Lagos. J Tehran Heart Cent. 2017;12(4):160–6.PubMedPubMedCentral
55.
56.
Attia TH, Morsy SM, Hassan BA, Ali ASA. Kawasaki disease among Egyptian children: a case series. Glob Cardiol Sci Pract. 2017;2017(3):e201725.PubMedPubMedCentral
57.
Hamza HS, Raouf WA, Zaher AZ, Agha HM. Acute Kawasaki disease with emphasis on the echocardiographic profile: a single center experience. Glob Cardiol Sci Pract. 2017;2017(3):e201725.
58.
El Ahmer I, Ben Haj Khalifa A, Tlijeni A, Wannes S, Boussofara R, Farhat J, et al. Incomplete Kawasaki Disease following meningococcal serogroup B meningitis. Austin J Microbiol. 2017;3(1):1016.
59.
60.
Shahin AA, Zayed HS, Elrefai RM, Taher H, Elsaie A, Senara SH, Fathi HM, Omar G, Abd Elazeem MI. The distribution and outcome of vasculitic syndromes among Egyptians: a multi-centre study including 630 patients. Egypt Rheumatologist. 2018;40(4):243–8.CrossRef
61.
Ben Chehida A, Ben Messaoud S, Ben Abdelaziz R, Boudabous H, Oujra M, Ben Turkia H, et al. High frequency of cardiovascular complications in Kawasaki Disease patients: need for a further awareness. J Trop Pediatr. 2019;65(3):217–23.PubMedCrossRef
62.
Jrad M, Ben Salem F, Barhoumi C, Lassoued F, Frikha W, Boukriba S, et al. The role of computed tomography coronary angiography in Kawasaki Disease: comparison with transthoracic echocardiography in a 25-case retrospective study. Pediatr Cardiol. 2019;40(2):265–75.PubMedCrossRef
63.
Elqadiry R, Louachama O, Rada N, Draiss G, Bouskraoui M. Late treatment and recurrence of Kawasaki Disease in a Moroccan infant. Case Rep Pediatr. 2019;2019:3904932.PubMedPubMedCentral
64.
Thabet H, Halima NB, Sghaier A. Successful management of a child with Kawasaki disease complicated by acute myocardial infarction. Cor et Vasa. 2019;61(5):524–8.CrossRef
65.
Hsairi M, Hammemi F, Safi F, Eleuch A, Koubaa M, Gargouri L, et al. A febrile skin rash may hide another. Eur J Basic Med Sci. 2019;9(1):1–4.CrossRef
66.
Hilda T, Emma N, Judith N, Aliku T, Peter L, Sulaiman L. Coronary artery involvement following Kawasaki Disease: a case report of a 5 month old African infant. Int Arch Cardiovasc Dis. 2019;3:025.
67.
Furia FF, Godfrey E, Mwamanenge N, Swai P. Spectrum of paediatric rheumatic disorders at a tertiary hospital in Tanzania. Pediatr Rheumatol Online J. 2020;18(1):30.PubMedPubMedCentralCrossRef
68.
Sow PS, Sow A, Boiro D, Dieye S, Diagne G, Bop K, et al. Kawasaki disease: about a case in Senegal. J Clin Rev Case Rep. 2020;5(6):303–5.
69.
Ech-Chebab M, Rkain M, Babakhouya A, Sbiaa Y, Ghannam A, Elouali A, Benajiba N. Atypical Kawasaki in a 15-month-old infant: diagnosis is not always easy. World J Cardiovasc Dis. 2020;10:483–7.CrossRef
70.
Wonodi W, Okari TG. Kawasaki disease in Port Harcourt, Nigeria. Port Harcourt Med J. 2020;14:154–8.CrossRef
71.
Salam Salih SA, Elbashier AMA, Alameen NAA. Familial Kawasaki disease and acute glomerulonephritis: case report and review of literature. Sudan J Paediatr. 2020;20(1):68–72.PubMedPubMedCentralCrossRef
72.
73.
74.
Rassas A, Guizani R, Werdani A, Jammeli N, Mahjoub B. Kawasaki disease shock syndrome complicated by coronary aneurysms: a case report. Pan Afr Med J. 2021;38:52.PubMedPubMedCentralCrossRef
75.
Anass A, Brahim H, Salah S, Abdelhakim Y, Rachid A, Amale H, et al. Resistant Kawasaki disease in an infant causing giant coronary aneurysms with thrombosis. J Cardio Case Rep. 2021;4:1–3.CrossRef
76.
Enuyma CA, Amajor AC, Akpah EU, Brown-Abang ES. Kawasaki disease; rare or misdiagnosed: a case report in a tertiary hospital in Nigeria. Calabar J Health Sci. 2021;5(1):35–9.CrossRef
77.
Animasahun BA, Ezegamba CO, Kayode-Awe O, Ogbuokiri EU, Akinola D. A narrative of a cohort of patients with Kawasaki disease seen at the Lagos State University Teaching Hospital. Ann Infect. 2021;5:2.CrossRef
78.
Tengbeh G, Mohsenibod H. 14-month-old girl with prolonged fever, a desquamative rash, and a new left hemiplegia. Trop Doct. 2022;52(2):349–50.PubMedCrossRef
79.
Musa A, Olorukooba AA, Abdullahi SM, Musa S, Makarfi HU. Kawasaki Disease associated with streptococcal infection and facial nerve palsy: a case report. Kanem J Med Sci. 2022;16(1):77–80.
80.
Ekoto MC, Ousmanou HI, Fondop J, Ondo JF, Ndombo PO. Kawasaki Disease in black Africa: about a case in an eight-year-old girl in Dschang. J Pediatr Dis Neonatal Care. 2022;5:102.
81.
Kuissi Kamgaing E, Lembet Mikolo A, Minto’o Rogombe S, Koumba Maniaga R, Mitoulou C, Mintsa-Mi-Nkama E, et al. Aspects épidémiologiques et thérapeutiques de la maladie de Kawasaki à Libreville de 2014 à 2021. Health Sci Dis. 2022;23(8):45–50.
82.
Guedenon KM, Attah DB, Akolly DA, Fiawoo M, Agbo-Kpati KP, Gbadoe AD. Kawasaki Disease in a Togolese child. Open J Pediatr. 2022;12(2):293–6.CrossRef
83.
Bouayed K, Lotfi S, Sakhi A, Driguil A. Double coronary aneurisms in Kawasaki Disease successfully treated with Anakinra: a case report. Archives Clin Med Case Rep. 2022;6:780–3.
84.
Ajmi H, Ghorbel S, Ezzi O, Mabrouk S, Mansour K, Kahloul N, et al. Les complications coronaires de la maladie de Kawasaki et ses facteurs de risque: à propos de 65 cas d’enfants tunisien. Ann de Cardiologie et d’Angéiologie. 2022;71(2):86–9.CrossRef
85.
Bekkar MM, Said KO, Ghomari SM, Tari A. Clinical characteristics and outcomes of Kawasaki Disease in infants younger than six months of age: Algerian Multicenter Study. SVOA Paediatrics. 2023;2(2):50–8.CrossRef
86.
Mebrouk N, Chtouki L, Bentahila A. Epidemiological profile and management of Kawasaki syndrome at Rabat Children’s hospital: a retrospective study from Morocco. Asian J Pediatr Res. 2023;12(2):13–22.CrossRef
87.
Kolié O, Bangoura MA, Camara E, Camara SH, Barry MC, Kouyaté M. Kawasaki Disease, a case report from the paediatric department of the Donka National Hospital, Chu Conakry (Guinea). Medicon Med Sci. 2023;4(5):36–9.
88.
Abushhaiwia A, Algaryani R, Zletni MA, Ashur ST, Alrabte HS, Jdour SS. Clinical patterns of Kawasaki Disease and factors associated with echocardiography abnormalities at presentation; Libyan experience. IJISRT. 2023;8(6):844–50.
89.
Sokunbi O, Akinbolagbe Y, Akintan P, Oyeleke G, Kusimo O, Owowo O, et al. Clinical presentation and short-term outcomes of multisysemic inflammatory syndrome in children in Lagos, Nigeria during the COVID-19 pandemic: a case series. eClinicalMedicine. 2022;49:101475.PubMedPubMedCentralCrossRef
Metadata
Title
Kawasaki disease in Kenya and review of the African literature
Authors
A. Migowa
CM. Njeru
E. Were
T. Ngwiri
I. Colmegna
C. Hitchon
R. Scuccimarri
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Pediatric Rheumatology / Issue 1/2024
Electronic ISSN: 1546-0096
DOI
https://doi.org/10.1186/s12969-024-00977-1

Other articles of this Issue 1/2024

Pediatric Rheumatology 1/2024 Go to the issue

Research article

Barriers and facilitators to medical care retention for pediatric systemic lupus erythematosus in South Africa: a qualitative study

Research article

Level and correlates of physical activity among children and adolescents with juvenile idiopathic arthritis compared to controls: results from a German nationwide prospective observational cohort study

Research article

Activated phosphoinositide 3-kinase δ syndrome caused by PIK3CD mutations: expanding the phenotype

Letter to the Editor

Juvenile idiopathic recurrent parotitis (JIRP) treated with short course steroids, a case series study and one decade follow up for potential autoimmune disorder

Research article

Exploring paediatric rheumatology care: a ten-year retrospective analysis of the patient population in Ghana

Research article

Adherence to low-dose methotrexate in children with juvenile idiopathic arthritis using a sensitive methotrexate assay